Common Stock, Value, Issued in USD of Neuphoria Therapeutics Inc. from Q2 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Neuphoria Therapeutics Inc. quarterly Common Stock, Value, Issued history and change rate from Q2 2024 to Q3 2025.
  • Neuphoria Therapeutics Inc. Common Stock, Value, Issued for the quarter ending 30 Sep 2025 was $23.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

Neuphoria Therapeutics Inc. Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23 30 Sep 2025 10-Q 14 Nov 2025 2025 Q1
Q2 2025 $19 +$8 +73% 30 Jun 2025 10-Q 14 Nov 2025 2025 Q1
Q1 2025 $19 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 $16 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2
Q2 2024 $11 30 Jun 2024 10-K 29 Sep 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.